QGEN - Company ID 0001015820
The table below shows QIAGEN N.V.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.09B | $1.98B | $1.97B | $2.14B | $2.25B | $1.87B |
| Cost of revenue | $790.50M | $1.01B | $731.62M | $756.96M | $800.84M | $637.63M |
| Gross profit | $1.30B | $967.35M | $1.23B | $1.38B | $1.45B | $1.23B |
| R&D | - | - | - | - | - | - |
| SG&A |
QIAGEN N.V. reported annual revenue of $2.09B for fiscal year 2025. That is up 5.7% from $1.98B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.34B (FY 2016) to $2.09B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $125.68M |
| $113.43M |
| $119.25M |
| $129.72M |
| $128.08M |
| $111.68M |
| Operating income | $465.85M | $97.71M | $409.94M | $531.46M | $630.08M | $386.43M |
| Income tax | $65.39M | $37.56M | $88.51M | $89.39M | $113.23M | $80.28M |
| Net income | $424.88M | $83.59M | $341.30M | $423.21M | $512.60M | $359.19M |
| EPS (diluted) | $1.94 | $0.37 | $1.48 | $1.84 | $2.21 | $1.53 |